8.7.5 Delegations

19 June 2020: any MRCA Treatment Pathway 1 and Treatment Pathway 2 information below has been retained for historical purposes only.  A Single Treatment Pathway has been in effect since 12 December 2019. See section 8.1 Overview [2] for current information.

Determination of claims for liability and compensation (including treatment) are made in accordance with section 333 [3] of the MRCA.  In relation to treatment this means any decision pursuant to paragraph 271(1)(c), 271(2)(c), 272(b) and 273(c) that treatment was reasonable in the circumstances.  The delegation for section 333 [3] is at the APS 5 level and above.

A — PS 3 level delegates and above are able to determine the amount of compensation payable for Pathway 1 treatment pursuant to section 276(1) [4].

Further information on delegations is contained at paragraph 1.3 in Chapter 1 [5] of this manual.